K.R. Mangalam University Hosts Groundbreaking International AI Pharma Conference
Gurugram, India – The School of Medical and Allied Sciences at K. R. Mangalam University is spearheading a pivotal moment in pharmaceutical innovation with the launch of the two-day international conference, “Pharma and Allied Sciences in the Age of AI: Innovations and IPR Strategies (PASAI-2026),” taking place April 27-28, 2026, in hybrid mode.
More than 600 leading academicians, industry experts, researchers, and policymakers from India and around the world have converged to share urgent breakthroughs in AI-driven drug discovery, healthcare innovation, and intellectual property rights strategies. The event unfolds against the backdrop of rapid advances reshaping Pharma across the globe.
AI Revolutionizing Pharmaceutical Research and Intellectual Property
The conference is aggressively tackling the critical integration of artificial intelligence in pharmaceutical sciences, aiming to turbocharge affordable medicine development, enhance disease diagnosis, and streamline healthcare treatments worldwide. Top-tier organizations supporting this event include the Department of Scientific and Industrial Research (DSIR), Anusandhan National Research Foundation (ANRF), and Haryana State Council for Science and Technology.
Participants will engage in keynote lectures, expert panel discussions, technical sessions, and hands-on workshops on patent search and drafting. Selected innovators will receive detailed patentability reports and professional guidance to fast-track their intellectual property filings—an unprecedented boost for startups and pharmaceutical innovators alike.
High-Profile Leadership and Global Expertise
The inauguration features heavyweight dignitaries including Dr. Ashok A. Sonkusare (Deputy Adviser, NITI Aayog), Harish K. Jain (National President, FOPE), and Dr. Vipul Kumar Gupta (Head of Corporate Affairs, Cipla Limited), reinforcing the event’s strategic importance. The keynote will be delivered by Dr. Vipin Shukla from India’s Ministry of Science and Technology.
Esteemed academics from elite institutes such as IIT BHU Varanasi, Maharaja Ranjit Singh Punjab Technical University, NIPER Mohali, and BITS Pilani provide a cutting-edge global perspective. This converges diverse expertise to fuel robust dialogue on the future of AI-powered pharmaceutical science.
Driving Atmanirbhar Bharat and Global Healthcare Impact
PASAI-2026 is not simply an academic assembly but a strategic initiative aimed at strengthening India’s self-reliance in high-tech pharmaceutical innovation, aligning with the Atmanirbhar Bharat vision. By accelerating AI applications and intellectual property commercialization, the event is expected to catalyze the startup ecosystem, stimulate job creation, and enhance healthcare accessibility worldwide.
The collaborative effort by K. R. Mangalam University’s leadership team, including Chancellor Prof. Dinesh Singh and Vice-Chancellor Prof. Meharajudin Mir, underscores the institution’s commitment to advancing scientific innovation with real-world impact.
Why U.S. Readers Should Watch This Space
Pharmaceutical innovation powered by AI is a global race, and developments like PASAI-2026 signal accelerating momentum that will influence healthcare markets everywhere, including the United States and North Carolina’s burgeoning biotech sectors. Breakthroughs in patent strategies and drug discovery methods presented here could rapidly reshape global supply chains and treatment paradigms.
With growing transnational collaboration and hybrid participation, the conference offers a rare window into cutting-edge research trends that matter to healthcare professionals, policymakers, and investors stateside seeking to stay ahead in an evolving pharmaceutical landscape.
The conference runs through April 28. Immediate updates and exclusives will be tracked for readers eager to witness the latest AI innovations transforming health sciences now.
